Fields marked as * are required.

 
 

vorsetuzumab mafodotin (SGN-75) / Seattle Genetics 
login

 17 Diseases   0 Investigators   2 Trials   5 News 
Show Filter Advanced
2 Trials

Remove Filter

 
TitleNRegionInterventionsSponsorStatusConditionsEndPhData-201420152016+
vorsetuzumab mafodotin (SGN-75) / Seattle Genetics
58
US
SGN-75
Seattle Genetics, Inc.
Completed
Carcinoma, Renal Cell, Lymphoma, Non-Hodgkin
11/11
1
      
Diamond
4
US
SGN-75, everolimus
Seattle Genetics, Inc.
Terminated
Renal Cell Carcinoma
12/13
1
      
Checkmark

Download Options
Help
Data releaseClick for data release
Data release (new)Click for data release (new)
Results pendingResults pending
Milestone resultClick for milestone result
Milestone result (new)Click for milestone result (new)
Milestone detailsClick for milestone details
MilestonesDisplay milestones
Phase 
N/A
0
1
2
3
4


Please login to post a comment.

Comments

No comments yet.